Monashee Investment Management LLC
An institutional investment manager in Boston, MA. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 13, 2026. SEC CIK 1627608.
- Reported value$59.6m
- Positions23
Holdings: 23 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$k | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Alphabet Inc | DEP SHS RP1/20 A | 02079K404 | 5,089 | 8.5% | 100,000 | New+100,000 | |
| Alphabet Inc | DEP SHS RP1/20 B | 02079K602 | 5,030 | 8.4% | 100,000 | New+100,000 | |
| Solid Biosciences IncSLDB | COM NEW | 83422E204 | 4,995 | 8.4% | 500,000 | Reduced−920,295 | |
| Digital Rlty TR IncDLR | COM | 253868103 | 4,490 | 7.5% | 25,000 | New+25,000 | |
| Spyre Therapeutics IncSYRE | COM NEW | 00773J202 | 4,439 | 7.5% | 50,000 | New+50,000 | |
| ADT Inc DelADT | COM | 00090Q103 | 3,900 | 6.5% | 600,000 | Reduced−100,000 | |
| Tango Therapeutics IncTNGX | COM | 87583X109 | 3,126 | 5.2% | 100,000 | New+100,000 | |
| Celcuity Inc | NOTE 0.250% 8/0 | 15102KAB6 | 2,839 | 4.8% | $2,500,000 principal | New+2,500,000 | |
| Super Micro Computer Inc | 7 DEP CM SR A WI | 86800U500 | 2,598 | 4.4% | 50,000 | New+50,000 | |
| Legend Biotech CorpLEGN | SPONSORED ADS | 52490G102 | 2,466 | 4.1% | 85,385 | New+85,385 | |
| Alphabet IncGOOGL | CAP STK CL A | 02079K305 | 2,144 | 3.6% | 6,000 | New+6,000 | |
| Alphabet IncGOOGL | CAP STK CL C | 02079K107 | 2,120 | 3.6% | 6,000 | New+6,000 | |
| Uniqure NV | SHS | N90064101 | 2,073 | 3.5% | 45,000 | New+45,000 | |
| Innio NV | ORDINARY SHARES | N52A8C105 | 1,885 | 3.2% | 47,650 | New+47,650 | |
| Acadia Rlty TRAKR | COM SH BEN INT | 004239109 | 1,785 | 3.0% | 85,385 | New+85,385 | |
| Pattern Group IncPTRN | COM SER A | 70339W104 | 1,613 | 2.7% | 64,039 | New+64,039 | |
| Purecycle Technologies Inc | NOTE 4.750% 7/0 | 74623VAD5 | 1,535 | 2.6% | $1,500,000 principal | New+1,500,000 | |
| Moonlake ImmunotherapeuticsMLTX | CLASS A ORD | 61559X104 | 1,460 | 2.5% | 75,000 | New+75,000 | |
| Whitehawk Minerals CorpWHK | CL A | 96524T101 | 1,425 | 2.4% | 51,232 | New+51,232 | |
| Taysha Gene Therapies IncTSHA | COM SHS | 877619106 | 1,362 | 2.3% | 200,000 | New+200,000 | |
| Imagenebio IncIMA | COM | 45175G207 | 1,135 | 1.9% | 192,344 | New+192,344 | |
| Nuvation Bio Inc | NOTE 0.750% 7/0 | 67080NAA9 | 1,056 | 1.8% | $1,000,000 principal | New+1,000,000 | |
| Kardigan IncKARD | COM | 485925101 | 1,018 | 1.7% | 42,693 | New+42,693 |
Sold out: 43 positions
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Aclaris Therapeutics IncACRS | COM | 00461U105 | 0.0 | 0.0% | 0 | Sold out−500,000 | |
| Ambiq Micro IncAMBQ | COMMON STOCK | 023193105 | 0.0 | 0.0% | 0 | Sold out−103,756 | |
| AST Spacemobile IncASTS | COM CL A | 00217D100 | 0.0 | 0.0% | 0 | Sold out−45,000 | |
| Bitgo Holdings IncBTGO | COM SHS CL A | 091947101 | 0.0 | 0.0% | 0 | Sold out−150,000 | |
| Bridgebio Pharma IncBBIO | COM | 10806X102 | 0.0 | 0.0% | 0 | Sold out−67,139 | |
| Coherent CorpCOHR | COM | 19247G107 | 0.0 | 0.0% | 0 | Sold out−5,000 | |
| Compass Therapeutics IncCMPX | COM | 20454B104 | 0.0 | 0.0% | 0 | Sold out−258,865 | |
| Crispr Therapeutics AG | NAMEN AKT | H17182108 | 0.0 | 0.0% | 0 | Sold out−50,000 | |
| Cytokinetics IncCYTK | COM NEW | 23282W605 | 0.0 | 0.0% | 0 | Sold out−100,000 | |
| Energy Vault Holdings IncNRGV | COM | 29280W109 | 0.0 | 0.0% | 0 | Sold out−176,453 | |
| Engene Holdings Inc | COM | 29286M105 | 0.0 | 0.0% | 0 | Sold out−320,000 | |
| Evommune IncEVMN | COM SHS | 30054Y107 | 0.0 | 0.0% | 0 | Sold out−179,340 | |
| Figure Technology SolutioFIGR | COM CL A | 349381103 | 0.0 | 0.0% | 0 | Sold out−76,520 | |
| Flowco Holdings IncFLOC | COM CL A | 342909108 | 0.0 | 0.0% | 0 | Sold out−100,000 | |
| Forgent Power Solutions IncFPS | COM SHS CL A | 34631F102 | 0.0 | 0.0% | 0 | Sold out−350,000 | |
| Globalfoundries Inc | ORDINARY SHARES | G39387108 | 0.0 | 0.0% | 0 | Sold out−50,000 | |
| Gossamer Bio Inc | NOTE 5.000% 6/0 | 38341PAA0 | 0.0 | 0.0% | 0 | Sold out−2,167,000 | |
| Hallador Energy CompanyHNRG | COM | 40609P105 | 0.0 | 0.0% | 0 | Sold out−90,000 | |
| Helix Acquisition Corp III | USD CL A ORD SHS | G4444S107 | 0.0 | 0.0% | 0 | Sold out−137,113 | |
| Ingram Micro HLDG CorpINGM | COM | 457152106 | 0.0 | 0.0% | 0 | Sold out−100,000 | |
| Janus Living IncJAN | CL A-1 | 471024109 | 0.0 | 0.0% | 0 | Sold out−50,000 | |
| Joby Aviation Inc | NOTE 0.750% 2/1 | 47775AAA9 | 0.0 | 0.0% | 0 | Sold out−7,000,000 | |
| KKR & Co Inc | 6.25 CON SER D | 48251W500 | 0.0 | 0.0% | 0 | Sold out−100,000 | |
| Kymera Therapeutics IncKYMR | COM | 501575104 | 0.0 | 0.0% | 0 | Sold out−35,100 | |
| Medline IncMDLN | COM CL A | 58507V107 | 0.0 | 0.0% | 0 | Sold out−300,000 | |
| Minimed Group IncMMED | COM | 60365F109 | 0.0 | 0.0% | 0 | Sold out−175,000 | |
| Navigator Holdings Ltd | SHS | Y62132108 | 0.0 | 0.0% | 0 | Sold out−75,000 | |
| Nektar TherapeuticsNKTR | COM NEW | 640268306 | 0.0 | 0.0% | 0 | Sold out−100,000 | |
| Nextera Energy Inc | UNIT 02/15/2029 | 65339F655 | 0.0 | 0.0% | 0 | Sold out−299,970 | |
| NRG Energy IncNRG | COM NEW | 629377508 | 0.0 | 0.0% | 0 | Sold out−85,000 | |
| Oracle Corp | 6.5 DEP CUM SR D | 68389X204 | 0.0 | 0.0% | 0 | Sold out−100,000 | |
| PPL Corp | UNIT 02/15/2029 | 69351T866 | 0.0 | 0.0% | 0 | Sold out−101,300 | |
| SAB Biotherapeutics IncSABS | COM NEW | 78397T202 | 0.0 | 0.0% | 0 | Sold out−500,000 | |
| Sandisk CorpSNDK | COM | 80004C200 | 0.0 | 0.0% | 0 | Sold out−5,000 | |
| Satellos Bioscience IncMSLE | COM | 80401L803 | 0.0 | 0.0% | 0 | Sold out−12,000 | |
| Spyglass Pharma IncSGP | COM SHS | 85220G109 | 0.0 | 0.0% | 0 | Sold out−95,000 | |
| Structure Therapeutics IncGPCR | SPONSORED ADS | 86366E106 | 0.0 | 0.0% | 0 | Sold out−50,000 | |
| Terns Pharmaceuticals Inc | COM | 880881107 | 0.0 | 0.0% | 0 | Sold out−300,000 | |
| Veradermics IncMANE | COMMON STOCK | 922967104 | 0.0 | 0.0% | 0 | Sold out−50,000 | |
| VIR Biotechnology IncVIR | COM | 92764N102 | 0.0 | 0.0% | 0 | Sold out−100,000 | |
| Whitefiber Inc | SHS | G96115103 | 0.0 | 0.0% | 0 | Sold out−80,000 | |
| Zenas Biopharma Inc | NOTE 2.500% 4/0 | 98937LAA3 | 0.0 | 0.0% | 0 | Sold out−3,152,000 | |
| Zenas Biopharma IncZBIO | COM | 98937L105 | 0.0 | 0.0% | 0 | Sold out−150,000 |
Source: SEC EDGAR, Form 13F-HR, accession 0001172661-26-003357 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.